Christopher J. Senner - Aug 11, 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP and CFO
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Aug 11, 2022
Transactions value $
-$1,542,382
Form type
4
Date filed
8/12/2022, 08:23 PM
Previous filing
Aug 5, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $1.4M +225K +50.46% $6.21 671K Aug 11, 2022 Direct F1
transaction EXEL Common Stock Tax liability -$2.94M -153K -22.79% $19.23 518K Aug 11, 2022 Direct F2
holding EXEL Common Stock 2.72K Aug 11, 2022 By 401(k) F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -225K -100% $0.00* 0 Aug 11, 2022 Common Stock 225K $6.21 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 166,412 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
F2 Represents a "net exercise" of an outstanding stock option. The Reporting Person received 225,000 shares of Common Stock on the net exercise of a stock option to purchase 72,133 shares of Common Stock. The Issuer withheld 152,867 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using the closing price of Common Stock on August 11, 2022 of $19.23.
F3 Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of August 11, 2022.
F4 The option, representing the right to purchase a total of 225,000 shares of Common Stock, became fully exercisable on September 16, 2019.